3P Learning Director Buys Amid Market-Implied Turnaround Doubt: A Contrarian Signal in a Shrinking EdTech

The setup here is a textbook case of a company in a severe downturn. The market has already delivered a brutal verdict, with 3P Learning's market cap collapsing by 72.60% over the past year to a current level of just $81.87 million. That's a wipeout of over $450 million in value since its peak, a decline that mirrors the broader post-pandemic reset in education technology.

The financials confirm the pressure. In its first-half 2026 earnings report, the company posted a 2% decline in revenue to AU$51.9 million, but the real red flag was the 16% collapse in underlying EBITDA to AU$5.7 million. This disproportionate drop signals deteriorating unit economics and rising costs, a classic sign of a business struggling to scale profitably. Management itself was not satisfied, citing elevated churn in its core B2B segment as a key challenge.

In response, the company has launched a strategic review focused on unit economics and cost management. This isn't a minor tweak; it's a full reassessment of the business model under duress. The director's recent purchase, therefore, stands as a symbolic gesture against this clear headwind. It's a vote of confidence at a moment when the company is actively trying to fix its fundamentals, a move that echoes historical patterns where insiders buy during periods of maximum pessimism.

The Signal: A Director's Purchase in a Weak Market

The specific transaction is a modest one: director Matthew Sandblom increased his indirect holding by 1,200 fully paid ordinary shares at an average price of $0.45 per share. This adds a small amount of capital to his already massive stake of over 136 million shares. In isolation, such a routine, on-market purchase might be dismissed as administrative or routine. Yet, its timing against the recent market backdrop gives it a sharper edge.

Academic research provides a crucial lens. A study from the University of Notre Dame finds that insider purchases have very strong return predictability, while sales are often driven by personal financial needs unrelated to the company's prospects. This makes purchases a potentially stronger signal. However, the research also cautions that not all buys carry equal weight. The signal is clearest when purchases are large, concentrated, or made when the stock is trading at a discount to intrinsic value.

The timing here is telling. The purchase occurred after the stock had already fallen 9.86% to $0.32 per share on the back of the weak first-half earnings report. This is the classic setup where insiders are said to act: when the market's pessimism is at its peak and the share price has been unfairly punished. As one perspective notes, when the market unfairly affects some share prices, company directors know that is the time to buy. In this context, Sandblom's move can be read as a symbolic vote of confidence, a quiet bet that the company's strategic review will eventually restore value. It's a signal that, from the inside, the current price may not reflect the long-term potential.

Historical Analogy: Insider Buying During Market Distress

The director's purchase fits a well-documented pattern of behavior that has played out across market cycles. The structural difference is clear: company directors are more likely to buy when prices are low, while private investors often stop investing in tough times. As one market observer notes, private investors tend to invest when equity markets are high and stop investing when equity markets are low. This creates a natural divergence in buying pressure, with insiders often acting as contrarians when the herd flees.

This divergence is driven by a powerful behavioral bias. Research from the University of Notre Dame shows that insider sales at a loss are less common than expected, suggesting a psychological aversion to selling at a loss may drive director buying. The study finds that when insiders sell stock for a loss, the stock's subsequent six-month return is significantly worse. The reasoning is straightforward: selling a stock at a loss is painful, so an insider who does so must have particularly negative information. This makes sales at a loss a strong predictor of future underperformance, while purchases, especially at depressed prices, signal a lack of that negative information.

Viewed through this lens, the director's move is not a unique signal for 3P Learning. It is a structural feature of market dynamics. When the market unfairly punishes share prices, as it has with this company, directors are more likely to step in. As one perspective puts it, when the market unfairly affects some share prices, company directors know that is the time to buy. This pattern has been observed repeatedly, including a recent week where 17 UK directors bought their own companies' shares for every one that sold. The takeaway is that this behavior is a recurring feature of market distress, not an isolated vote of confidence.

The Counterweight: Structural Challenges and Valuation

The insider signal must be weighed against a stark reality: 3P Learning's valuation implies growth that its financials are not delivering. The company trades at a trailing P/E ratio of 66.68, a multiple that prices in robust future expansion. Yet this premium sits atop a business that just reported a 2% decline in revenue and a 16% collapse in underlying EBITDA. The disconnect is the core tension. A high P/E suggests investors expect a turnaround, but the recent earnings show the company is still contracting.

The pressure is most acute in the B2B segment, the core of its institutional business. Management cited elevated customer churn as a key problem, directly causing a 3% revenue decline in that unit. For a subscription model, this is a fundamental vulnerability. It signals that the company is losing customers faster than it can replace them, undermining the very recurring revenue stream that should provide stability. This churn-driven contraction is what makes the strategic review so critical-and so uncertain.

The stock's price action reflects deep skepticism about that review's outcome. The share price is down 9.86% to $0.32 following the weak report, trading near the bottom of its 52-week range of $0.26 to $0.80. This discount to its highs isn't just about the past earnings; it's a forward bet that the company's problems are structural, not temporary. The market is pricing in the risk that the strategic review will not quickly restore growth or profitability.

In this light, the director's purchase looks like a bet against the consensus. It's a quiet vote that the current price, trading at a discount and with a high P/E, misprices the potential of the strategic fix. Yet the valuation itself is a counterweight. A P/E of 67 demands a successful turnaround, not just a stabilization. The insider signal is a contrarian whisper, but the financial metrics and the stock's deep discount are the louder, more immediate warnings.

Catalysts and Risks: What to Watch

The path forward hinges on a few clear milestones. The primary catalyst is the outcome of the company's strategic review, which is expected to provide clarity on unit economics and cost management. This review is the central response to the deteriorating financials, and its conclusions will dictate the next phase of the turnaround. Investors will be watching for specific plans to address the elevated churn and restore profitability, particularly in the core B2B segment.

The key metrics to monitor are sequential changes in churn rates and B2B segment performance. The recent 3% revenue decline in that unit due to churn is a fundamental vulnerability. Any stabilization or improvement in customer retention will be the first tangible sign that the strategic review is having an effect. Conversely, continued deterioration would validate the market's skepticism and likely pressure the stock further.

The major risk is that the strategic review fails to arrest the revenue decline. If the company cannot quickly stabilize its B2B business, the revenue contraction will persist, leading to further margin pressure. This would undermine the high valuation multiple that already prices in a successful turnaround. The stock's deep discount to its highs reflects this very risk-the market is betting that the problems are structural, not temporary. Without a clear plan to reverse the trend, the valuation compression could accelerate, turning a contrarian signal into a costly bet.